Literature DB >> 17683870

Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils.

M Cansev1, R J Wurtman.   

Abstract

Synthesis of phosphatidylcholine, the most abundant brain membrane phosphatide, requires three circulating precursors: choline; a pyrimidine (e.g. uridine); and a polyunsaturated fatty acid. Supplementing a choline-containing diet with the uridine source uridine-5'-monophosphate (UMP) or, especially, with UMP plus the omega-3 fatty acid docosahexaenoic acid (given by gavage), produces substantial increases in membrane phosphatide and synaptic protein levels within gerbil brain. We now compare the effects of various polyunsaturated fatty acids, given alone or with UMP, on these synaptic membrane constituents. Gerbils received, daily for 4 weeks, a diet containing choline chloride with or without UMP and/or, by gavage, an omega-3 (docosahexaenoic or eicosapentaenoic acid) or omega-6 (arachidonic acid) fatty acid. Both of the omega-3 fatty acids elevated major brain phosphatide levels (by 18-28%, and 21-27%) and giving UMP along with them enhanced their effects significantly. Arachidonic acid, given alone or with UMP, was without effect. After UMP plus docosahexaenoic acid treatment, total brain phospholipid levels and those of each individual phosphatide increased significantly in all brain regions examined (cortex, striatum, hippocampus, brain stem, and cerebellum). The increases in brain phosphatides in gerbils receiving an omega-3 (but not omega-6) fatty acid, with or without UMP, were accompanied by parallel elevations in levels of pre- and post-synaptic proteins (syntaxin-3, PSD-95 and synapsin-1) but not in those of a ubiquitous structural protein, beta-tubulin. Hence administering omega-3 polyunsaturated fatty acids can enhance synaptic membrane levels in gerbils, and may do so in patients with neurodegenerative diseases, especially when given with a uridine source, while the omega-6 polyunsaturated fatty acid arachidonic acid is ineffective.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683870      PMCID: PMC2048660          DOI: 10.1016/j.neuroscience.2007.06.016

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  92 in total

1.  Differential utilization of 1-palmitoyl and 1-stearoyl homologues of various unsaturated 1,2-diacyl-sn-glycerols for phosphatidylcholine and phosphatidylethanolamine synthesis in rat liver microsomes.

Authors:  B J Holub
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

2.  A simple, rapid, and sensitive DNA assay procedure.

Authors:  C Labarca; K Paigen
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

3.  Carrier mediated blood-brain barrier transport of choline and certain choline analogs.

Authors:  E M Cornford; L D Braun; W H Oldendorf
Journal:  J Neurochem       Date:  1978-02       Impact factor: 5.372

4.  Choline kinase and ethanolamine kinase activity in the cytosol of nerve endings from rat forebrain.

Authors:  S Spanner; G B Ansell
Journal:  Biochem J       Date:  1979-03-15       Impact factor: 3.857

5.  The differential incorporation of labelled linoleic, gamma-linolenic, dihomo-gamma-linolenic and arachidonic acids into the developing rat brain.

Authors:  A G Hassma; M A Crawford
Journal:  J Neurochem       Date:  1976-10       Impact factor: 5.372

6.  Kinetic properties of arachidonoyl-coenzyme A synthetase in rat brain microsomes.

Authors:  T S Reddy; N G Bazan
Journal:  Arch Biochem Biophys       Date:  1983-10-01       Impact factor: 4.013

7.  Selective incorporation of polyunsaturated fatty acids into phosphatidylcholine by rat liver microsomes.

Authors:  W E Lands; M Inoue; Y Sugiura; H Okuyama
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

8.  Choline and cholinergic neurons.

Authors:  J K Blusztajn; R J Wurtman
Journal:  Science       Date:  1983-08-12       Impact factor: 47.728

9.  Choline administration elevates brain phosphorylcholine concentrations.

Authors:  W R Millington; R J Wurtman
Journal:  J Neurochem       Date:  1982-06       Impact factor: 5.372

10.  Synthesis and metabolism of arachidonyl- and eicosapentaenoyl-CoA in rat aorta.

Authors:  N Morisaki; Y Saito; A Kumagai
Journal:  Biochim Biophys Acta       Date:  1983-07-12
View more
  35 in total

1.  Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: secondary analyses from a randomized, controlled trial.

Authors:  P J G H Kamphuis; F R J Verhey; M G M Olde Rikkert; J W R Twisk; S H N Swinkels; P Scheltens
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

2.  Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial.

Authors:  P J G H Kamphuis; F R J Verhey; M G M Olde Rikkert; J W R Twisk; S H N Swinkels; P Scheltens
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

Review 3.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

Authors:  Richard J Wurtman; Mehmet Cansev; Toshimasa Sakamoto; Ismael Ulus
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

4.  Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus.

Authors:  Toshimasa Sakamoto; Mehmet Cansev; Richard J Wurtman
Journal:  Brain Res       Date:  2007-09-21       Impact factor: 3.252

Review 5.  Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides.

Authors:  R J Wurtman; M Cansev; I H Ulus
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

Review 6.  Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents.

Authors:  Richard J Wurtman
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

7.  Dietary intake, nutrition, and fetal alcohol spectrum disorders in the Western Cape Province of South Africa.

Authors:  Philip A May; Kari J Hamrick; Karen D Corbin; Julie M Hasken; Anna-Susan Marais; Lesley E Brooke; Jason Blankenship; H Eugene Hoyme; J Phillip Gossage
Journal:  Reprod Toxicol       Date:  2014-02-22       Impact factor: 3.143

8.  Exercise contributes to the effects of DHA dietary supplementation by acting on membrane-related synaptic systems.

Authors:  Gabriela Chytrova; Zhe Ying; Fernando Gomez-Pinilla
Journal:  Brain Res       Date:  2009-05-13       Impact factor: 3.252

9.  Maternal nutritional status as a contributing factor for the risk of fetal alcohol spectrum disorders.

Authors:  Philip A May; Kari J Hamrick; Karen D Corbin; Julie M Hasken; Anna-Susan Marais; Jason Blankenship; H Eugene Hoyme; J Phillip Gossage
Journal:  Reprod Toxicol       Date:  2015-12-03       Impact factor: 3.143

10.  Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease.

Authors:  Mehmet Cansev; Ismail H Ulus; Lei Wang; Timothy J Maher; Richard J Wurtman
Journal:  Neurosci Res       Date:  2008-08-03       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.